For citations:
Galstyan G.R., Galyavich A.S., Grineva E.N., Gurevich V.S., Ezhov M.V., Kalashnikov V.Yu., Karpov Yu.A., Mkrtumyan A.M., Nedogoda S.V., Smolenskaya O.G., Shlyakhto E.V., Yakovlev A.N. Lipid-lowering treatment in the improvement of outcomes in patients with atherosclerotic cardiovascular disease and diabetes mellitus: the role of PCSK9 inhibitors. Russian Journal of Cardiology. 2018;(12):103-106. (In Russ.)
Email this article 